AzTrials
AzTrials

Anterior Knee PainNCT07842913

Hybrid Telerehabilitation for Anterior Knee Pain in Routine Physiotherapy Practice

A study testing Hybrid Telerehabilitation in people with Anterior Knee Pain, run by Farraj Miguel at 2 sites in 2 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study will examine how hybrid telerehabilitation is used in routine physiotherapy care for adults with anterior knee pain. Approximately 30 participants will be followed for 72 weeks while receiving individualized treatment from their physiotherapist, supported by the moveUP mobile application. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anterior Knee Pain
What is being tested?
Hybrid Telerehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
2 sitesin 2 countries
Study dates
Sep 2026to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older.
  • Clinical diagnosis of anterior knee pain, including patellofemoral pain, patellar tendinopathy, Hoffa's fat pad syndrome, chondromalacia, or femoropatellar, tibiopatellar, or tibiofemoral osteoarthritis not requiring surgery.
  • Access to a smartphone compatible with the moveUP application.

Who cannot join

  • Currently awaiting spine or lower-limb surgery.
  • Lower-limb surgery or other invasive intervention within the previous two years.
  • Joint prosthesis.
  • Acute trauma to the trunk or lower limbs, or fracture, dislocation, or other musculoskeletal pathology of the affected lower limb within the previous six months.
  • Saphenous nerve neuritis or Ehlers-Danlos syndrome.
  • Severe osteoarthritis requiring joint replacement, systemic inflammatory joint disease (including rheumatoid arthritis or gout), or joint infection.
Show all 10Show fewer
  • Persistent low back pain lasting three months or longer.
  • Vascular, respiratory, or neurological conditions that interfere with participation.
  • Cognitive or psychiatric impairment limiting application use or communication.
  • Pregnancy.

Trial locations and contacts

2 sites in 2 countries. Contact the study team or a site near you to ask about taking part.

Miguel Farraj, PhD candidate contact

+32494035113

miguel.farraj@ulb.be

2 sites in 2 countries

Belgium1 site, 1 recruiting
  • Private clinics

    Brussels

    Miguel Farraj, PhD candidate, +32494035113, miguel.farraj@ulb.be

    Recruiting

Other trials in Belgium

France1 site, 1 recruiting
  • Private clinics

    Paris

    Miguel Farraj, PhD candidate, +32494035113, miguel.farraj@ulb.be

    Recruiting

Other trials in France

About this study

Official title: Integrating Hybrid Telerehabilitation Into Routine Physiotherapy Practice for Anterior Knee Pain: Protocol for a Real-World Pragmatic Mixed-Methods Study

This study will examine how hybrid telerehabilitation is used in routine physiotherapy care for adults with anterior knee pain. Approximately 30 participants will be followed for 72 weeks while receiving individualized treatment from their physiotherapist, supported by the moveUP mobile application. The application provides prescribed exercises, educational information, communication with the physiotherapist, and progress monitoring.

The study will assess adherence to rehabilitation, pain, knee function, quality of life, psychological factors, and physical activity. It will also explore whether patient adherence and physiotherapist engagement are associated with clinical outcomes. Interviews with patients and healthcare professionals will examine barriers and facilitators to using the platform in routine care.

Being tested
Hybrid Telerehabilitation
Keywords
Telerehabilitation, Exercise Adherence, Mobile Health, Physiotherapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hybrid TelerehabilitationBehavioural

    Hybrid telerehabilitation combining routine physiotherapy with the moveUP mobile application for adults with anterior knee pain. The platform supports individualized exercise prescription, educational modules, patient-physiotherapist communication, and progress monitoring. Exercise selection, frequency, and progression are determined by the treating physiotherapist according to patient needs. Participants are followed for 72 weeks.

Study groups in NCT07842913
Study groupRoleWhat they receive
Hybrid TelerehabilitationExperimentalParticipants receive individualized physiotherapy for anterior knee pain supported by the moveUP mobile application over 72 weeks. Treatment is prescribed and adapted by the treating physiotherapist according to individual patient needs.
Receives: Behavioral: Hybrid Telerehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Exercise Adherence (ATEMPT Score)

    Exercise adherence will be assessed using the Adherence to Exercise for Musculoskeletal Pain Tool (ATEMPT). Total scores range from 6 to 30, with higher scores indicating greater adherence.

    Measured: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

  2. Pain Intensity (Visual Analog Scale)

    Pain intensity will be measured using a 0-100 mm Visual Analog Scale (VAS), where 0 indicates no pain and 100 indicates the worst pain imaginable. Higher scores indicate greater pain intensity.

    Measured: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

Secondary outcomes (5)
  1. Knee Function (Anterior Knee Pain Scale)

    The Anterior Knee Pain Scale assesses symptoms and functional limitations associated with anterior knee pain. The total score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms

    Measured: aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

  2. Health-Related Quality of Life (EQ-5D)

    Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Responses will be converted into a utility index using the Belgian value set. Scores range from -0.532 to 1, with higher scores indicating better health-related quality of life.

    Measured: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

  3. Fear of Movement (Tampa Scale for Kinesiophobia)

    The 11-item Tampa Scale for Kinesiophobia assesses fear of movement or reinjury. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia and therefore a worse outcome

    Measured: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

  4. Pain Catastrophizing (Pain Catastrophizing Scale)

    The Pain Catastrophizing Scale is a 13-item questionnaire assessing catastrophic thoughts related to pain. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing and therefore a worse outcome

    Measured: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72

  5. Physical Activity (Daily Step Count)

    Measured: Daily/weekly

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2026
  2. Study startSep 2026 (estimated)
  3. Primary completionMay 2028 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07842913
Sponsor's protocol ID
AIM2-AKP-001
Other IDs
2024-RDIR-5c
Status last verified
Sep 2026
First submitted
21 Sep 2026
Last updated
30 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Hybrid Telerehabilitation in people with Anterior Knee Pain, run by Farraj Miguel at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium, France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Miguel Farraj, PhD candidate (+32494035113, miguel.farraj@ulb.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Exercise Adherence (ATEMPT Score) (time frame: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in